Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE

BACKGROUND: Consensus treatment plans have been developed for induction therapy of newly diagnosed proliferative lupus nephritis (LN) in childhood-onset systemic lupus erythematosus. However, patients who do not respond to initial therapy, or who develop renal flare after remission, warrant escalati...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilbert, Mileka, Goilav, Beatrice, Hsu, Joyce J., Nietert, Paul J., Meidan, Esra, Chua, Annabelle, Ardoin, Stacy P., Wenderfer, Scott E., von Scheven, Emily, Ruth, Natasha M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404338/
https://www.ncbi.nlm.nih.gov/pubmed/34461932
http://dx.doi.org/10.1186/s12969-021-00627-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404338/
https://www.ncbi.nlm.nih.gov/pubmed/34461932
http://dx.doi.org/10.1186/s12969-021-00627-w

Ejemplares similares